Noga Brunicki (M. Sc) has over 13 years of experience within the Israeli pharmaceutical, medical device, life science and health care industry.
Having a deep and well-established know-how, she is responsible for reliably and efficiently supporting phase I-IV studies in multiple therapeutic areas, both for medical device and medicinal products. Her expertise includes the entire scope from the early design and set-up of study plans through monitoring and management and up to wrapping up and reporting the results. Noga had gained remarkable experience working for GlaxoSmithKline (GSK) in Israel where she was exposed to a very high level, state of the art, clinical research aspects in a global team environment.
Since 2008 Noga works in the CRO business providing services to a wide variety of companies while keeping the ability to custom design a strategy that will fit to each one of them based on their individual needs. Using her long term strategic relationship with the Israeli sites, she brings the clinical study to be almost integrated into the clinical routine. Her solid academic background is due to graduating from two prestigious institutions in Israel: Weizmann institute of science (Rehovot) as well as Israel’s Institute of Technology (Technion, Haifa).
Within AICROS she is responsible to cover Israel as well as business development activities.
Noga is Vice President of AICROS since 2022